___

• Aamar E, Frank D (2004). Xenopus Meis3 protein forms a hindbraininducing center by activating FGF/MAP kinase and PCP pathways. Development 131: 153-163.
• Abate-Shen C (2002). Deregulated homeobox gene expression in cancer: cause or consequence? Nature Reviews Cancer 2: 777- 785.
• Abbaszadegan MR, Moghbeli M (2018). Role of MAML1 and MEIS1 in esophageal squamous cell carcinoma depth of invasion. Pathology & Oncology Research 24: 245-250.
• Agoston Z, Heine P, Brill MS, Grebbin BM, Hau AC et al. (2014). Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb. Development 141: 28-38.
• Aksoz M, Turan RD, Albayrak E, Kocabas F (2018). Emerging roles of meis1 in cardiac regeneration, stem cells and cancer. Current Cancer Drug Targets 19: 181-190.
• Alvarado-Ruiz L, Martinez-Silva MG, Torres-Reyes LA, Pina-Sanchez P, Ortiz-Lazareno P et al. (2016). HOXA9 is underexpressed in cervical cancer cells and its restoration decreases proliferation, migration and expression of epithelial-to-mesenchymal transition genes. Asian Pacific Journal of Cancer Prevention 17: 1037-1047.
• Ando H, Natsume A, Senga T, Watanabe R, Ito I et al. (2014). Peptidebased inhibition of the HOXA9/PBX interaction retards the growth of human meningioma. Cancer Chemother Pharmacol 73: 53-60.
• Argani P, Reuter VE, Kapur P, Brown JE, Sung YS et al. (2018). Novel MEIS1-NCOA2 gene fusions define a distinct primitive spindle cell sarcoma of the kidney. The American Journal of Surgical Pathology 42: 1562-1570.
• Arkin MR, Tang Y, Wells JA (2014). Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Cell Chemical Biology 21: 1102-1114.
• Arkin MR, Wells JA (2004). Small-molecule inhibitors of proteinprotein interactions: progressing towards the dream. Nature Reviews Drug Discovery 3: 301-317.
• Aulisa L, Forraz N, McGuckin C, Hartgerink JD (2009). Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater 5: 842-853.
• Azcoitia V, Aracil M, Martinez AC, Torres M (2005). The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Developmental Biology 280: 307-320.
• Bach DH, Lee SK (2018). Long noncoding RNAs in cancer cells. Cancer Letters 419: 152-166.
• Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS et al. (2015). Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecologic Oncology 137: 14-22.
• Bell A, Bell D, Weber RS, El-Naggar AK (2011). CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer 117: 2898-2909.
• Berdasco M, Ropero S, Setien F, Fraga MF, Lapunzina P et al. (2009). Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proceedings of the National Academy of Sciences (Proceedings of the National Academy of Sciences of the United States of America) 106: 21830-21835.
• Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T et al. (2016). Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS One 11: e0147236.
• Beukers W, Hercegovac A, Vermeij M, Kandimalla R, Blok AC et al. (2013). Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages. The Journal of Urology 190: 311-316.
• Beukers W, Kandimalla R, van Houwelingen D, Kovacic H, Chin JF et al. (2013). The use of molecular analyses in voided urine for the assessment of patients with hematuria. PLoS One 8: e77657.
• Bhanvadia RR, VanOpstall C, Brechka H, Barashi NS, Gillard M et al. (2018). MEIS1 and MEIS2 expression and prostate cancer progression: a role for HOXB13 binding partners in metastatic disease. Clinical Cancer Research 24: 3668-3680.
• Bhatlekar S, Viswanathan V, Fields JZ, Boman BM (2018). Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation. Journal of Cellular Physiology 233: 727-735.
• Blasi F, Bruckmann C, Penkov D, Dardaei L (2017). A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer. Bioessays 39 (5): 1600245.
• Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences 99: 15524- 15529.
• Calvo KR, Knoepfler P, McGrath S, Kamps MP (1999). An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene 18: 8033-8043.
• Cantile M, Cindolo L, Napodano G, Altieri V, Cillo C (2003). Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene 22: 6462-6468.
• Cantile M, Scognamiglio G, La Sala L, La Mantia E, Scaramuzza V et al. (2013). Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers. International Journal of Molecular Sciences 14: 21727-21740.
• Carè A, Silvani A, Meccia E, Mattia G, Stoppacciaro A et al. (1996). HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Molecular and Cellular Biology 16: 4842-4851.
• Carninci P, Hayashizaki Y (2007). Noncoding RNA transcription beyond annotated genes. Current Opinion in Genetics & Development 17: 139-144.
• Carrera M, Bitu CC, de Oliveira CE, Cervigne NK, Graner E et al. (2015). HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 8: 3613-3623.
• Carroll AJ, Crist WM, Parmley RT, Roper M, Cooper M et al. (1984). Pre-B cell leukemia associated with chromosome translocation 1: 19. Blood 63 (3): 721-724.
• Chang C-P, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG et al. (1997). Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Molecular and Cellular Biology 17: 5679-5687.
• Chang CJ, Chen YL, Hsieh CH, Liu YJ, Yu SL et al. (2017). HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer. Journal of Cancer 8: 1071-1081.
• Chen F, Li Y, Wang L, Hu L (2011). Knockdown of BMI-1 causes cellcycle arrest and derepresses p16INK4a, HOXA9 and HOXC13 mRNA expression in HeLa cells. Medical Oncology 28: 1201- 1209.
• Chen G, Xie Y (2018). miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells. OncoTargets and Therapy 11: 1909-1920.
• Chen JL, Li J, Kiriluk KJ, Rosen AM, Paner GP et al. (2012). Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Clinical Cancer Research 18: 4291-4302.
• Chen QY, Des Marais T, Costa M (2019). Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control. Carcinogenesis 40: 393-402.
• Chen R, Smith-Cohn M, Cohen AL, Colman H (2017). Glioma Subclassifications and their Clinical Significance. Neurotherapeutics 14: 284-297.
• Chen YC, Tsao CM, Kuo CC, Yu MH, Lin YW et al. (2015). Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis. Taiwanese Journal of Obstetrics & Gynecology 54: 572-579.
• Cheng Y, Jutooru I, Chadalapaka G, Corton JC, Safe S (2015). The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. Oncotarget 6: 10840- 10852.
• Choe SK, Vlachakis N, Sagerstrom CG (2002). Meis family proteins are required for hindbrain development in the zebrafish. Development 129: 585-595.
• Chong GO, Jeon HS, Han HS, Son JW, Lee YH et al. (2017). Overexpression of microRNA-196b accelerates invasiveness of cancer cells in recurrent epithelial ovarian cancer through regulation of Homeobox A9. Cancer Genomics Proteomics 14: 137-141.
• Co M, Anderson AG, Konopka G (2020). FOXP transcription factors in vertebrate brain development, function, and disorders. Wiley Interdisciplinary Reviews-Developmental Biology 9 (5): e375.
• Collins CT, Hess JL (2016). Deregulation of the HOXA9/MEIS1 axis in acute leukemia. Current Opinion in Hematology 23: 354- 361.
• Comacchio GM, Marulli G, Mammana M, Natale G, Schiavon M et al. (2019). Surgical decision making: thymoma and myasthenia gravis. Thoracic Surgery Clinics 29: 203-213.
• Crijns AP, de Graeff P, Geerts D, Ten Hoor KA, Hollema H et al. (2007). MEIS and PBX homeobox proteins in ovarian cancer. European Journal of Cancer 43: 2495-2505.
• Crist RC, Roth JJ, Waldman SA, Buchberg AM (2011). A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. PLoS One 6: e23665.
• Cui L, Li M, Feng F, Yang Y, Hang X et al. (2014). MEIS1 functions as a potential AR negative regulator. Experimental Cell Research 328: 58-68.
• Dancsok AR, Asleh-Aburaya K, Nielsen TO (2017). Advances in sarcoma diagnostics and treatment. Oncotarget 8: 7068-7093.
• Dard A, Reboulet J, Jia Y, Bleicher F, Duffraisse M et al. (2018). Human HOX proteins use diverse and context-dependent motifs to interact with TALE class cofactors. Cell Reports 22: 3058-3071.
• Dardaei L, Longobardi E, Blasi F (2014). Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proceedings of the National Academy of Sciences (Proceedings of the National Academy of Sciences of the United States of America) 111: E896-905.
• de Weille J (2014). On the genesis of neuroblastoma and glioma. International Journal of Brain Science 2014: 1-14.
• Decker B, Ostrander EA (2014). Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer. Pharmacogenomics and Personalized Medicine 7: 193-201.
• Dekel B, Metsuyanim S, Schmidt-Ott KM, Fridman E, Jacob-Hirsch J et al. (2006). Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Research 66: 6040-6049.
• Deramaudt TB, Sachdeva MM, Wescott MP, Chen Y, Stoffers DA et al. (2006). The PDX1 homeodomain transcription factor negatively regulates the pancreatic ductal cell-specific keratin 19 promoter. Journal of Biological Chemistry 281: 38385- 38395.
• Di Leva G, Garofalo M, Croce CM (2014). MicroRNAs in cancer. Annual Review of Pathology: Mechanisms of Disease 9: 287- 314.
• Di Zanni E, Fornasari D, Ravazzolo R, Ceccherini I, Bachetti T (2015). Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells. Experimental Cell Research 336: 43-57.
• Dihal AA, Boot A, van Roon EH, Schrumpf M, Farina-Sarasqueta A et al. (2013). The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors. PLoS One 8: e79898.
• Doolan P, Clynes M, Kennedy S, Mehta JP, Germano S et al. (2009). TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer. Tumor Biology 30: 200-209.
• Drosopoulos K, Linardopoulos S (2019) Integration of RNAi and small molecule screens to identify targets for drug development. In: Target Identification and Validation in Drug Discovery. Springer, pp 33-42.
• Du J, Zhang L (2015). Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome. Oncology Reports 34: 585-594.
• Duan R, Han L, Wang Q, Wei J, Chen L et al. (2015). HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget 6: 27778.
• Dudek P, Picard D (2008). Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells. PLoS One 3: e1859.
• Errico MC, Felicetti F, Bottero L, Mattia G, Boe A et al. (2013). The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. International Journal of Cancer 133: 879-892.
• Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN et al. (2009). HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 113: 2375-2385.
• Feng X, Li T, Liu Z, Shi Y, Peng Y (2015). HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome. Molecular BioSystems 11: 2946-2954.
• Feng X, Zhang C, Zhu L, Zhang L, Li H et al. (2017). DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma. Oncotarget 8: 63605.
• Fiskus W, Pranpat M, Balasis M, Herger B, Rao R et al. (2006). Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Molecular Cancer Therapeutics 5: 3096- 3104.
• Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y et al. (2017). LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Letters 410: 68-81.
• Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG et al. (2001). Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Experimental Hematology 29: 856-863.
• Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG et al. (2001). Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Experimental Hematology 29: 856-863.
• Gajula RP, Chettiar ST, Williams RD, Thiyagarajan S, Kato Y et al. (2013). The twist box domain is required for Twist1-induced prostate cancer metastasis. Molecular Cancer Research 11: 1387-1400.
• Gao L, Smit MA, van den Oord JJ, Goeman JJ, Verdegaal EM et al. (2013). Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma. Pigment Cell & Melanoma Research 26: 542-554.
• Garcia-Cuellar MP, Steger J, Fuller E, Hetzner K, Slany RK (2015). Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia. Haematologica 100: 905-913.
• Geerts D, Schilderink N, Jorritsma G, Versteeg R (2003). The role of the MEIS homeobox genes in neuroblastoma. Cancer Letters 197: 87-92.
• Grebbin BM, Hau AC, Gross A, Anders-Maurer M, Schramm J et al. (2016). Pbx1 is required for adult subventricular zone neurogenesis. Development 143: 2281-2291.
• Grubach L, Juhl-Christensen C, Rethmeier A, Olesen LH, Aggerholm A et al. (2008). Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. European Journal of Haematology 81: 112-122.
• Gu S, Gu W, Shou J, Xiong J, Liu X et al. (2017). The molecular feature of HOX gene family in the intramedullary spinal tumors. The Spine Journal 42: 291-297.
• Guan Y, He Y, Lv S, Hou X, Li L et al. (2019). Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Journal of Drug Targeting 27: 60-66.
• Guerrero-Preston R, Soudry E, Acero J, Orera M, Moreno-Lopez L et al. (2011). NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prevention Research 4: 1061-1072.
• Guo YB, Shao YM, Chen J, Xu SB, Zhang XD et al. (2016). Effect of overexpression of HOX genes on its invasive tendency in cerebral glioma. Oncology Letters 11: 75-80.
• Han B, Huang J, Han Y, Hao J, Wu X et al. (2019). The microRNA miR181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin. International Journal of Biological Macromolecules 125: 544- 556.
• Han HB, Gu J, Ji DB, Li ZW, Zhang Y et al. (2014). PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway. World Journal of Gastroenterology 20: 18260-18270.
• Hansel DE, Rahman A, House M, Ashfaq R, Berg K et al. (2004). Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clinical Cancer Research 10: 6152-6158.
• Hau AC, Grebbin BM, Agoston Z, Anders-Maurer M, Muller T et al. (2017). MEIS homeodomain proteins facilitate PARP1/ ARTD1-mediated eviction of histone H1. Journal of Cell Biology 216: 2715-2729.
• Hayes J, Peruzzi PP, Lawler S (2014). MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20: 460- 469.
• Higashi K, Yamagishi T, Ueda Y, Ishigaki Y, Shimasaki M et al. (2016). Correlation of HIF-1alpha/HIF-2alpha expression with FDG uptake in lung adenocarcinoma. Annals of Nuclear Medicine 30: 708-715.
• Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T et al. (2014). Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS One 9: e89885.
• Hu H, Chen Y, Cheng S, Li G, Zhang Z (2017). Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer. Wien Klin Wochenschr 129: 391-397.
• Hu L, Li H, Huang CL, Chen H, Zhu G et al. (2014). Regulation of myeloid ecotropic viral integration site 1 and its expression in normal and abnormal endometrium. Fertil Steril 102: 856-863 e852.
• Huang X, Ding L, Bennewith KL, Tong RT, Welford SM et al. (2009). Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular Cell 35: 856-867.
• Hung YC, Ueda M, Terai Y, Kumagai K, Ueki K et al. (2003). Homeobox gene expression and mutation in cervical carcinoma cells. Cancer Science 94: 437-441.
• Jacques C, Guillotin D, Fontaine JF, Franc B, Mirebeau-Prunier D et al. (2013). DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors. The Journal of Clinical Endocrinology and Metabolism 98: E981-989.
• Jeong JH, Park SJ, Dickinson SI, Luo JL (2017). A constitutive intrinsic inflammatory signaling circuit composed of miR-196b, Meis2, PPP3CC, and p65 drives prostate cancer castration resistance. molecular cell 65: 154-167.
• Jia Y, Bleicher F, Merabet S (2018). A systematic survey of HOX and TALE expression profiling in human cancers. The International Journal of Developmental Biology 62: 865-876.
• Johng D, Torga G, Ewing CM, Jin K, Norris JD et al. (2019). HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer. Prostate 79: 414-424.
• Jones TA, Flomen RH, Senger G, Nizetic D, Sheer D (2000). The homeobox gene MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines. European Journal of Cancer 36: 2368-2374.
• Ju T, Jin H, Ying R, Xie Q, Zhou C et al. (2017). Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells. Molecular Medicine Reports 16: 3194-3200.
• Jung JG, Shih IM, Park JT, Gerry E, Kim TH et al. (2016). Ovarian cancer chemoresistance relies on the stem cell reprogramming factor PBX1. Cancer Research 76: 6351-6361.
• Kanai M, Hamada J, Takada M, Asano T, Murakawa K et al. (2010). Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas. Oncology Reports 23: 843-851.
• Karapetsas A, Tokamani M, Evangelou C, Sandaltzopoulos R (2018). The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer. Molecular Carcinogenesis 57: 1251-1263.
• Karatas H, Townsend EC, Cao F, Chen Y, Bernard D et al. (2013). High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction. Journal of the American Chemical Society 135: 669-682.
• Kempinska K, Malik B, Borkin D, Klossowski S, Shukla S et al. (2018). Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Molecular Cancer Therapeutics 17: 26-38.
• Kikugawa T, Kinugasa Y, Shiraishi K, Nanba D, Nakashiro K et al. (2006). PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Prostate 66: 1092-1099.
• Kim JW, Kim JY, Kim JE, Kim S-K, Chung H-T et al. (2014). HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes & Cancer 5: 165.
• Kim JW, Kim JY, Kim JE, Kim SK, Chung HT et al. (2014). HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes Cancer 5: 165-174.
• Kim KT, Lee CH, Chung CK, Kim JH (2018). Is NF2 a key player of the differentially expressed gene between spinal cord ependymoma and intracranial ependymoma? World Neurosurgery 118: e906-e917.
• Kitchen MO, Bryan RT, Haworth KE, Emes RD, Luscombe C et al. (2015). Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One 10: e0137003.
• Ko SY, Barengo N, Ladanyi A, Lee JS, Marini F et al. (2012). HOXA9 promotes ovarian cancer growth by stimulating cancerassociated fibroblasts. Journal of Clinical Investigation 122: 3603-3617.
• Ko SY, Naora H (2014). Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9. Cancer Cell & Microenvironment 1: e379.
• Ko SY, Naora H (2014). HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin. Molecular Cancer 13: 170.
• Kocabas F, Zheng J, Thet S, Copeland NG, Jenkins NA et al. (2012). Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 120: 4963-4972.
• Kocabas FT, RD. (2019). Australia Patent No. Patent Number|. Published Source: Issuing Organization|.
• Kocak H, Ackermann S, Hero B, Kahlert Y, Oberthuer A et al. (2013). Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death & Disease - Nature 4: e586.
• Koller K, Pichler M, Koch K, Zandl M, Stiegelbauer V et al. (2014). Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1. Pediatric and Developmental Pathology 17: 169-175.
• Lasa A, Carnicer MJ, Aventin A, Estivill C, Brunet S et al. (2004). MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. Leukemia 18: 1231-1237.
• Laurent A, Bihan R, Omilli F, Deschamps S, Pellerin I (2008). PBX proteins: much more than Hox cofactors. The International Journal of Developmental Biology 52: 9-20.
• Li H, Sun G, Liu C, Wang J, Jing R et al. (2017). PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer. OncoTargets and Therapy 10: 5685-5694.
• Li H, Wang J, Xu F, Wang L, Sun G et al. (2019a). By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells. Future Oncology 15: 1577-1591.
• Li J, Wang Y, Yu J, Dong R, Qiu H (2015a). A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumor Biology 36: 1661-1665.
• Li J, Wen W, Zhao S, Wang J, Chen J et al. (2015b). Prognostic role of HOTAIR in four estrogen-dependent malignant tumors: a meta-analysis. OncoTargets and Therapy 8: 1471-1482.
• Li Q, Feng Y, Chao X, Shi S, Liang M et al. (2018). HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b/MAPK1 axis. Bioscience Reports 38 (1): BSR20171563.
• Li Q, Lu J, Xia J, Wen M, Wang C (2019c). Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochemical and Biophysical Research Communications 512: 558-563.
• Li W, Huang K, Guo H, Cui G (2014). Meis1 regulates proliferation of non-small-cell lung cancer cells. Journal of Thoracic Disease 6: 850-855.
• Li Y, Sun F, Ma X, Qu H, Yu Y (2019b). MiR-888 promotes cell migration and invasion of hepatocellular carcinoma by targeting SMAD4. European Review for Medical and Pharmacological Sciences 23: 2020-2027.
• Lin C, Xie L, Lu Y, Hu Z, Chang J (2018). miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells. International Journal of Molecular Medicine 41: 2050- 2058.
• Lin CW, Wang LK, Wang SP, Chang YL, Wu YY et al. (2017). Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1alpha/HDAC1/Slug axis. Nature Communications 8: 14502.
• Lin L, Huang M, Shi X, Mayakonda A, Hu K et al. (2019). Superenhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWSFLI1. Nucleic Acids Research 47: 1255-1267.
• Liu H, Zhang M, Xu S, Zhang J, Zou J et al. (2018). HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFbeta1 in non-small cell lung cancer. Oncogenesis 7: 1.
• Liu J, Wang Y, Birnbaum MJ, Stoffers DA (2010). Three-aminoacid-loop-extension homeodomain factor Meis3 regulates cell survival via PDK1. Proceedings of the National Academy of Sciences (Proceedings of the National Academy of Sciences of the United States of America) 107: 20494-20499.
• Liu N, Liu Z, Zhang W, Li Y, Cao J et al. (2018). MicroRNA433 reduces cell proliferation and invasion in nonsmall cell lung cancer via directly targeting E2F transcription factor 3. Molecular Medicine Reports 18: 1155-1164.
• Liu Y, Wang Y, Yang H, Zhao L, Song R et al. (2019). MicroRNA873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/betacatenin pathway. International Journal of Oncology 54: 1809-1820.
• Liu Y, Xu X, Lin P, He Y, Zhang Y et al. (2019). Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. Journal of Biological Chemistry 294: 4572-4582.
• Liu Z, Piao L, Zhuang M, Qiu X, Xu X et al. (2017). Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis. Oncology Reports 38: 2796-2802.
• Lopez R, Garrido E, Vazquez G, Pina P, Perez C et al. (2006). A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer. International Journal of Gynecologic Cancer 16: 1289-1296.
• Lu YH, Gao XQ, Wu M, Zhang-Negrerie D, Gao Q (2011). Strategies on the development of small molecule anticancer drugs for targeted therapy. Mini-Reviews in Medicinal Chemistry 11: 611-624.
• Luo H, Xu C, Le W, Ge B, Wang T (2019). lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. Journal of Cellular Biochemistry 120: 13487-13493.
• Lv X, Tang Q, Tu Y, Yan D, Wei Q (2019). Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/βcatenin pathway and is a prognosis marker in cervical cancer. European Review for Medical and Pharmacological Sciences 23: 1947-1956.
• Mahmoud AI, Kocabas F, Muralidhar SA, Kimura W, Koura AS et al. (2013). Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497: 249-253.
• Makabe T, Arai E, Hirano T, Ito N, Fukamachi Y et al. (2019). Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer. Carcinogenesis 40: 611-623.
• Malakar P, Stein I, Saragovi A, Winkler R, Stern-Ginossar N et al. (2019). Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2. Cancer Research 79: 2480-2493.
• Malek R, Gajula RP, Williams RD, Nghiem B, Simons BW et al. (2017). TWIST1-WDR5-Hottip regulates Hoxa9 chromatin to facilitate prostate cancer metastasis. Cancer Research 77: 3181- 3193.
• Mallo M, Alonso CR (2013). The regulation of Hox gene expression during animal development. Development 140: 3951-3963.
• Manohar CF, Furtado MR, Salwen HR, Cohn SL (1993). Hox gene expression in differentiating human neuroblastoma cells. Biochemistry and Molecular Biology International 30: 733- 741.
• Manohar CF, Salwen HR, Furtado M, Cohn SL (1996). Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation. Tumor Biology 17: 34-47.
• Marciano R, Prasad M, Ievy T, Tzadok S, Leprivier G et al. (2019). High-throughput screening identified compounds sensitizing tumor cells to glucose starvation in culture and VEGF inhibitors in vivo. Cancers (Basel) 11 (2): 156.
• Marin-Muller C, Li D, Bharadwaj U, Li M, Chen C et al. (2013). A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clinical Cancer Research 19: 5901-5913.
• Marra L, Cantile M, Scognamiglio G, Perdonà S, La Mantia E et al. (2013). Deregulation of HOX B13 expression in urinary bladder cancer progression. Current medicinal chemistry 20: 833-839.
• Martinez-Fernandez M, Feber A, Duenas M, Segovia C, Rubio C et al. (2015). Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer. Clinical Epigenetics 7: 109.
• Milech N, Gottardo NG, Ford J, D’Souza D, Greene WK et al. (2010). MEIS proteins as partners of the TLX1/HOX11 oncoprotein. Leukemia Research 34: 358-363.
• Moghbeli M, Rad A, Farshchian M, Taghehchian N, Gholamin M et al. (2016). Correlation between Meis1 and Msi1 in esophageal squamous cell carcinoma. Journal of Gastrointestinal Cancer 47: 273-277.
• Mohr S, Doebele C, Comoglio F, Berg T, Beck J et al. (2017). Hoxa9 and Meis1 cooperatively induce addiction to syk signaling by suppressing miR-146a in acute myeloid leukemia. Cancer Cell 31: 549-562 e511.
• Montavon C, Gloss BS, Warton K, Barton CA, Statham AL et al. (2012). Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecologic Oncology 124: 582-588.
• Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C et al. (2012). Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Research and Treatment 136: 389-398.
• Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS (2010). Targeting HOX and PBX transcription factors in ovarian cancer. BMC cancer 10: 89.
• Moskow JJ, Bullrich F, Huebner K, Daar IO, Buchberg AM (1995). Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Molecular and Cellular Biology 15: 5434-5443.
• Mudgapalli N, Nallasamy P, Chava H, Chava S, Pathania AS et al. (2019). The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities. Molecular Aspects of Medicine 70: 21-32.
• Mueller DW, Bosserhoff AK (2011). MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. International Journal of Cancer 129: 1064-1074.
• Muralidhar SA, Sadek HA (2016) Meis1 regulates postnatal cardiomyocyte cell cycle arrest. In: Etiology and Morphogenesis of Congenital Heart Disease. Springer, Tokyo, pp 93-101.
• Musialik E, Bujko M, Kober P, Wypych A, Gawle-Krawczyk K et al. (2015). Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia. Blood Research 50: 26-32.
• Niskakoski A, Kaur S, Staff S, Renkonen-Sinisalo L, Lassus H et al. (2014). Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Epigenetics 9: 1577-1587.
• Norgaard M, Haldrup C, Bjerre MT, Hoyer S, Ulhoi B et al. (2019). Epigenetic silencing of MEIS2 in prostate cancer recurrence. Clinical Epigenetics 11: 147.
• Okada S, Irie T, Tanaka J, Yasuhara R, Yamamoto G et al. (2015). Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis. Journal of Oral Pathology & Medicine 44: 115-125.
• Okumura K, Saito M, Isogai E, Aoto Y, Hachiya T et al. (2014). Meis1 regulates epidermal stem cells and is required for skin tumorigenesis. PLoS One 9: e102111.
• Palma CA, Al Sheikha D, Lim TK, Bryant A, Vu TT et al. (2014). MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Molecular Cancer Research 13: 79.
• Pan J, Qin Y, Zhang M (2016). HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway. Biomedicine & Pharmacotherapy 77: 176-181.
• Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2015). Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12). PLoS One 10: e0124288.
• Park JT, Shih Ie M, Wang TL (2008). Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer. Cancer Research 68: 8852-8860.
• Patel AV, Chaney KE, Choi K, Largaespada DA, Kumar AR et al. (2016). An ShRNA screen identifies MEIS1 as a driver of malignant peripheral nerve sheath tumors. EBioMedicine 9: 110-119.
• Paul S, Zhang X, He JQ (2020). Homeobox gene Meis1 modulates cardiovascular regeneration. Seminars in Cell and Developmental Biology 100: 52-61.
• Peng Y, Croce CM (2016). The role of MicroRNAs in human cancer. Signal Transduction and Targeted Therapy 1: 15004.
• Penkov D, Di Rosa P, Fernandez Diaz L, Basso V, Ferretti E et al. (2005). Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Molecular and Cellular Biology 25: 10768-10781.
• Peverali FA, D’Esposito M, Acampora D, Bunone G, Negri M et al. (1990). Expression of HOX homeogenes in human neuroblastoma cell culture lines. Differentiation 45: 61-69.
• Pillay LM, Forrester AM, Erickson T, Berman JN, Waskiewicz AJ (2010). The Hox cofactors Meis1 and Pbx act upstream of gata1 to regulate primitive hematopoiesis. Developmental Biology 340: 306-317.
• Platais C, Radhakrishnan R, Niklander Ebensperger S, Morgan R, Lambert DW et al. (2018). Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes. BMC Cancer 18: 723.
• Plowright L, Harrington KJ, Pandha HS, Morgan R (2009). HOX transcription factors are potential therapeutic targets in nonsmall-cell lung cancer (targeting HOX genes in lung cancer). British Journal of Cancer 100: 470-475.
• Polson ES, Kuchler VB, Abbosh C, Ross EM, Mathew RK et al. (2018). KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice. Science Translational Medicine 10 (454).
• Pontikakis S, Papadaki C, Tzardi M, Trypaki M, Sfakianaki M et al. (2017). Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy. The Pharmacogenomics Journal 17: 506-514.
• Popa I, Zubkova I, Medvedovic M, Romantseva T, Mostowski H et al. (2007). Regeneration of the adult thymus is preceded by the expansion of K5+K8+ epithelial cell progenitors and by increased expression of Trp63, cMyc and Tcf3 transcription factors in the thymic stroma. International Immunology 19: 1249-1260.
• Qiu Y, Morii E, Tomita Y, Zhang B, Matsumura A et al. (2009). Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma. Cancer Science 100: 1198-1209.
• Qiu Y, Wang ZL, Jin SQ, Pu YF, Toyosawa S et al. (2012). Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma. Journal of Zhejiang University Science B 13: 168-175.
• Qiu Z, Wang X, Shi Y, Da M (2019). miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Acta Biochimica et Biophysica Sinica 51: 997-1007.
• Rad A, Farshchian M, Forghanifard MM, Matin MM, Bahrami AR et al. (2016). Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma. Tumor Biology 37: 1715- 1725.
• Ramberg H, Alshbib A, Berge V, Svindland A, Tasken KA (2011). Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Molecular Cancer Research 10 : 50.
• Ramberg H, Grytli HH, Nygard S, Wang W, Ogren O et al. (2016). PBX3 is a putative biomarker of aggressive prostate cancer. International Journal of Cancer 139: 1810-1820.
• Rattay K, Meyer HV, Herrmann C, Brors B, Kyewski B (2016). Evolutionary conserved gene co-expression drives generation of self-antigen diversity in medullary thymic epithelial cells. Journal of Autoimmunity 67: 65-75.
• Rauch T, Wang Z, Zhang X, Zhong X, Wu X et al. (2007). Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proceedings of the National Academy of Sciences 104: 5527-5532.
• Redline RW, Hudock P, MacFee M, Patterson P (1994). Expression of AbdB-type homeobox genes in human tumors. Laboratory Investigation 71: 663-670.
• Renganathan A, Felley-Bosco E (2017) Long noncoding RNAs in cancer and therapeutic potential. In: Long Non Coding RNA Biology. Springer, pp 199-222.
• Richter GH, Fasan A, Hauer K, Grunewald TG, Berns C et al. (2013). G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1. The Journal of Pathology 230: 70-81.
• Rieckhof GE, Casares F, Ryoo HD, Abu-Shaar M, Mann RS (1997). Nuclear translocation of extradenticle requires homothorax, which encodes an extradenticle-related homeodomain protein. Cell 91: 171-183.
• Risolino M, Mandia N, Iavarone F, Dardaei L, Longobardi E et al. (2014). Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-beta-SMAD3 pathway in non-small cell lung adenocarcinoma. Proceedings of the National Academy of Sciences (Proceedings of the National Academy of Sciences of the United States of America) 111: E3775-3784.
• Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T (2018). Emerging roles of long non-coding RNA in cancer. Cancer Science 109: 2093-2100.
• Sarayloo F, Dionne-Laporte A, Catoire H, Rochefort D, Houle G et al. (2019). Mineral absorption is an enriched pathway in a brain region of restless legs syndrome patients with reduced MEIS1 expression. PLoS One 14: e0225186.
• Sarno JL, Kliman HJ, Taylor HS (2005). HOXA10, Pbx2, and Meis1 protein expression in the human endometrium: formation of multimeric complexes on HOXA10 target genes. The Journal of Clinical Endocrinology and Metabolism 90: 522-528.
• Scarlett CJ, Colvin EK, Pinese M, Chang DK, Morey AL et al. (2011). Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction. PLoS One 6: e26088.
• Schnabel CA, Jacobs Y, Cleary ML (2000). HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 19: 608-616.
• Schussel J, Zhou XC, Zhang Z, Pattani K, Bermudez F et al. (2013). EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clinical Cancer Research 19: 3268-3275.
• Shanmugam K, Green NC, Rambaldi I, Saragovi HU, Featherstone MS (1999). PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins. Molecular and Cellular Biology 19: 7577-7588.
• Shears L, Plowright L, Harrington K, Pandha HS, Morgan R (2008). Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. The Journal of Urology 180: 2196-2201.
• Shen W-F, Rozenfeld S, Kwong A, Kömüves LG, Lawrence HJ et al. (1999). HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Molecular and Cellular Biology 19: 3051-3061.
• Shi J, Guo J, Li X (2018). Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer. International Journal of Oncology 52: 179-188.
• Shi S, Zhao J, Wang J, Mi D, Ma Z (2017). HPIP silencing inhibits TGF-beta1-induced EMT in lung cancer cells. International Journal of Molecular Medicine 39: 479-483.
• Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y et al. (2007). Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 26: 339-348.
• Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI et al. (2010). The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7: 380-390.
• Sitwala KV, Dandekar MN, Hess JL (2008). HOX proteins and leukemia. International Journal of Clinical and Experimental Pathology 1: 461.
• Somers K, Chudakova DA, Middlemiss SM, Wen VW, Clifton M et al. (2016). CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements. Oncotarget 7: 46067.
• Somers K, Wen VW, Middlemiss SMC, Osborne B, Forgham H et al. (2019). A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction. Oncogene 38: 3824-3842.
• Song F, Wang H, Wang Y (2017). Myeloid ecotropic viral integration site 1 inhibits cell proliferation, invasion or migration in human gastric cancer. Oncotarget 8: 90050.
• Sonnet W, Rezsohazy R, Donnay I (2012). Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. Developmental Dynamics 241: 1827- 1839.
• Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik BD et al. (2001). The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 71: 214-221.
• St Laurent G, Wahlestedt C, Kapranov P (2015). The Landscape of long noncoding RNA classification. Trends in Genetics 31: 239-251.
• Staffas A, Arabanian LS, Wei SY, Jansson A, Stahlman S et al. (2017). Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice. Oncogene 36: 1516-1524.
• Stewart SL, Lakhani N, Brown PM, Larkin OA, Moore AR et al. (2013). Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions. Journal of Women’s Health 22: 651-657.
• Sun JC, He F, Yi W, Wan MH, Li R et al. (2015). High expression of HIF-2alpha and its anti-radiotherapy effect in lung cancer stem cells. Genetics and Molecular Research 14: 18110-18120.
• Sun X, Du P, Yuan W, Du Z, Yu M et al. (2015). Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer. Cell Death & Disease - Nature 6: e1907.
• Sun Y, Zhu Q, Zhou M, Yang W, Shi H et al. (2019). Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/beta-catenin signaling pathway via downregulating maternally expressed gene-3. Experimental and Therapeutic Medicine 17: 639-648.
• Swift GH, Liu Y, Rose SD, Bischof LJ, Steelman S et al. (1998). An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Molecular and Cellular Biology 18: 5109-5120.
• Takahashi Y, Hamada J, Murakawa K, Takada M, Tada M et al. (2004). Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Experimental Cell Research 293: 144-153.
• Tang L, Cao Y, Song X, Wang X, Li Y et al. (2019). HOXC6 promotes migration, invasion and proliferation of esophageal squamous cell carcinoma cells via modulating expression of genes involved in malignant phenotypes. Peer J 7: e6607.
• Tang Z, Li C, Kang B, Gao G, Li C et al. (2017). GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research 45: W98-W102.
• Thiaville MM, Stoeck A, Chen L, Wu RC, Magnani L et al. (2012). Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites. PLoS One 7: e36054.
• Thomas M, Gessner A, Vornlocher HP, Hadwiger P, Greil J et al. (2005). Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 106: 3559-3566.
• Thomsen CB, Andersen RF, Steffensen KD, Adimi P, Jakobsen A (2019). Delta tocotrienol in recurrent ovarian cancer. A phase II trial. Pharmacological Research 141: 392-396.
• Tomoeda M, Yuki M, Kubo C, Yoshizawa H, Kitamura M et al. (2011). Role of Meis1 in mitochondrial gene transcription of pancreatic cancer cells. Biochemical and Biophysical Research Communications 410: 798-802.
• Toresson H, Parmar M, Campbell K (2000). Expression of Meis and Pbx genes and their protein products in the developing telencephalon: implications for regional differentiation. Mechanisms of Development 94: 183-187.
• Tsuboi M, Taniuchi K, Shimizu T, Saito M, Saibara T (2017). The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells. Journal of Biological Chemistry 292: 17681-17702.
• Turan RD, Albayrak E, Uslu M, Siyah P, Alyazici LY et al. (2020). Development of small molecule MEIS inhibitors that modulate HSC activity. Scientific Reports 10: 1-17.
• Uchida K, Veeramachaneni R, Huey B, Bhattacharya A, Schmidt BL et al. (2014). Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis. BMC Cancer 14: 353.
• Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P et al. (2015). Proteomics. Tissue-based map of the human proteome. Science 347: 1260419.
• Uribe RA, Bronner ME (2015). Meis3 is required for neural crest invasion of the gut during zebrafish enteric nervous system development. Molecular Biology of the Cell 26: 3728-3740.
• Vastrad B, Vastrad C, Godavarthi A, Chandrashekar R (2017). Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Medical Oncology 34: 182.
• Vlachakis N, Choe S-K, Sagerstrom CG (2001). Meis3 synergizes with Pbx4 and Hoxb1b in promoting hindbrain fates in the zebrafish. Development 128: 1299-1312.
• von Burstin J, Bachhuber F, Paul M, Schmid RM, Rustgi AK (2017). The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells. Molecular Carcinogenesis 56: 936-944.
• Vriens MR, Moses W, Weng J, Peng M, Griffin A et al. (2011). Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117: 259-267.
• Vukovic M, Guitart AV, Sepulveda C, Villacreces A, O’Duibhir E et al. (2015). Hif-1alpha and Hif-2alpha synergize to suppress AML development but are dispensable for disease maintenance. Journal of Experimental Medicine 212: 2223-2234.
• Wan Z, Chai R, Yuan H, Chen B, Dong Q et al. (2019). MEIS2 promotes cell migration and invasion in colorectal cancer. Oncology Reports 42: 213-223.
• Wang GG, Pasillas MP, Kamps MP (2006). Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hoxpbx complexes on promoters of leukemia-associated genes. Molecular and Cellular Biology 26: 3902-3916.
• Wang H, Liu C, Liu X, Wang M, Wu D et al. (2018b). MEIS1 regulates hemogenic endothelial generation, megakaryopoiesis, and thrombopoiesis in human pluripotent stem cells by targeting TAL1 and FLI1. Stem Cell Reports 10: 447-460.
• Wang H, Qiu X, Lin S, Chen X, Wang T et al. (2018c). Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma. World Journal of Surgical Oncology 16: 64.
• Wang J, Xiao Q, Chen X, Tong S, Sun J et al. (2018d). LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway. Cell Death & Disease - Nature 9: 197.
• Wang K, Jin J, Ma T, Zhai H (2017a). MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9. Journal of Cellular and Molecular Medicine 21: 3730-3740.
• Wang M, Lv G, Jiang C, Xie S, Wang G (2019c). miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3. Scientific Reports 9: 2032.
• Wang M, Wang H, Wen Y, Chen X, Liu X et al. (2018a). MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1. Stem Cell Research & Therapy 9: 340.
• Wang TS, l. Vaal, M. Stoeck, A. Jung, JG. (2018f). USA Patent Number: US20180118688A1. .
• Wang X, Bu J, Liu X, Wang W, Mai W et al. (2017b). miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer. Oncotarget 8: 63935-63948.
• Wang X, Ghareeb WM, Zhang Y, Yu Q, Lu X et al. (2019b). Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. Journal of Cellular Physiology 234: 18180-18191.
• Wang Y, Hardin H, Chu YH, Esbona K, Zhang R et al. (2019a). Long non-coding RNA Expression in Anaplastic Thyroid Carcinomas. Endocrine Pathology 30: 262-269.
• Wang Y, Li D, Liu Y, Tian S, Chen X (2018e). Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma. Pathology - Research and Practice 214: 1340-1344.
• Waskiewicz AJ, Rikhof HA, Hernandez RE, Moens CB (2001). Zebrafish Meis functions to stabilize Pbx proteins and regulate hindbrain patterning. Development 128: 4139-4151.
• Watanabe Y, Saito M, Saito K, Matsumoto Y, Kanke Y et al. (2018). Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncology Letters 15: 2756- 2762.
• Wei G, Sun J, Hou Z, Luan W, Wang S et al. (2018). Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway. European Journal of Medicinal Chemistry 157: 759-772.
• Weller M, Wick W, Aldape K, Brada M, Berger M et al. (2015). Glioma. Nature Reviews Disease Primers 1: 15017.
• Wermuth PJ, Buchberg AM (2005). Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 105: 1222-1230.
• Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML (2007). Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes & Development 21: 2762-2774.
• Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O et al. (2017). Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma. BMC Med 15: 101.
• Wu C, Jin X, Tsueng G, Afrasiabi C, Su AI (2016). BioGPS: building your own mash-up of gene annotations and expression profiles. Nucleic Acids Research 44: D313-316.
• Wu C, Macleod I, Su AI (2013). BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Research 41: D561-565.
• Wu Q, Lothe RA, Ahlquist T, Silins I, Trope CG et al. (2007). DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Molecular Cancer Research 6: 45.
• Xavier-Magalhaes A, Goncalves CS, Fogli A, Lourenco T, Pojo M et al. (2018). The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget 9: 15740-15756.
• Xavier FC, Destro MF, Duarte CM, Nunes FD (2014). Epigenetic repression of HOXB cluster in oral cancer cell lines. Archives of Oral Biology 59: 783-789.
• Xia N, Tan W, Peng Q, Cai H (2019). MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1. European Review for Medical and Pharmacological Sciences 23: 513-521.
• Xiao F, Bai Y, Chen Z, Li Y, Luo L et al. (2014). Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. European Journal of Cancer 50: 1541-1554.
• Xie R, Chen X, Chen Z, Huang M, Dong W et al. (2019). Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Cancer Letters 449: 31-44.
• Xing BL, Li T, Tang ZH, Jiao L, Ge SM et al. (2015). Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer. Genetics and Molecular Research 14: 4532-4540.
• Xu X, Bao Z, Liu Y, Jiang K, Zhi T et al. (2018). PBX3/MEK/ERK1/2/ LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion. Journal of Experimental & Clinical Cancer Research 37: 158.
• Yang C, Xu X, Jin H (2016). Identification of potential miRNAs and candidate genes of cervical intraepithelial neoplasia by bioinformatic analysis. European Journal of Gynaecological Oncology 37: 469-473.
• Yang N, Liang Y, Yang P, Ji F (2017). Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer. Oncology Reports 37: 2611- 2619.
• Yang NJ, Hinner MJ (2015). Getting across the cell membrane: an overview for small molecules, peptides, and proteins. Methods in Molecular Biology 1266: 29-53.
• Yang P, Kang W, Pan Y, Zhao X, Duan L (2019). Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma. Cancer Management and Research 11: 8167-8179.
• Yarian F, Alibakhshi A, Eyvazi S, Arezumand R, Ahangarzadeh S (2019). Antibody-drug therapeutic conjugates: Potential of antibody-siRNAs in cancer therapy. Journal of Cellular Physiology 234: 16724-16738.
• Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M et al. (2010). Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecologic Oncology 117: 409-416.
• Yuan R, Zhang S, Yu J, Huang Y, Lu D et al. (2017). Beyond cancer genes: colorectal cancer as robust intrinsic states formed by molecular interactions. Open Biology 7: 170169.
• Zha Y, Xia Y, Ding J, Choi JH, Yang L et al. (2014). MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression. Cell Death & Disease - Nature 5: e1417.
• Zhan FB, Zhang XW, Feng SL, Cheng J, Zhang Y et al. (2019). MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis. Yonsei Medical Journal 60: 163-173.
• Zhang B, Li N, Zhang H (2018). Knockdown of Homeobox B5 (HOXB5) inhibits cell proliferation, migration, and invasion in non-small cell lung cancer cells through inactivation of the Wnt/beta-Catenin pathway. Oncology Research and Treatment 26: 37-44.
• Zhang H, Yao B, Tang S, Chen Y (2019). LINK-A Long non-coding RNA (lncRNA) participates in metastasis of ovarian carcinoma and upregulates Hypoxia-Inducible Factor 1 (HIF1alpha). Medical Science Monitor 25: 2221-2227.
• Zhang X, Friedman A, Heaney S, Purcell P, Maas RL (2002). Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. Genes & Development 16: 2097-2107.
• Zhang X, Rowan S, Yue Y, Heaney S, Pan Y et al. (2006). Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development. Developmental Biology 300: 748-757.
• Zhang Y, Cheng JC, Huang HF, Leung PC (2013). Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha. Biochemical and Biophysical Research Communications 440: 652-657.
• Zhang Y, Yu S, Jiang L, Wang X, Song X (2017). HOTAIR is a promising novel biomarker in patients with thyroid cancer. Experimental and Therapeutic Medicine 13: 2274-2278.
• Zheng DH, Wang X, Lu LN, Chen DL, Chen JM et al. (2018). MiR638 serves as a tumor suppressor by targeting HOXA9 in glioma. European Review for Medical and Pharmacological Sciences 22: 7798-7806.
• Zhou J, Wu J, Li B, Liu D, Yu J et al. (2014). PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway. Leukemia 28: 1436-1448.
• Zhu J, Cui L, Xu A, Yin X, Li F et al. (2017). MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration. BMC Cancer 17: 176.
• Zhu XL, Ai ZH, Wang J, Xu YL, Teng YC (2012). Weighted gene coexpression network analysis in identification of endometrial cancer prognosis markers. Asian Pacific Journal of Cancer Prevention 13: 4607-4611.
• Zhuang S, Liu F, Wu P (2019). Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis. Journal of Cellular Biochemistry 120: 13392-13402.
• Zutter M, Hockett RD, Roberts CW, McGuire EA, Bloomstone J et al. (1990). The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. Proceedings of the National Academy of Sciences (Proceedings of the National Academy of Sciences of the United States of America 87: 3161- 3165.